Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 561Leukemia 282Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Myelodysplastic Syndromes 110Congenital Abnormalities 86Leukemia, Monocytic, Acute 84Leukemia, Myelomonocytic, Acute 82Leukemia, Erythroblastic, Acute 75Leukemia, Megakaryoblastic, Acute 72Lymphoma 65Burkitt Lymphoma 62Recurrence 61Leukemia, Myelomonocytic, Chronic 43Leukemia, Biphenotypic, Acute 43Lymphoma, Non-Hodgkin 41Blast Crisis 37Anemia, Refractory, with Excess of Blasts 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Leukemia, Lymphocytic, Chronic, B-Cell 33Lymphoma, Large B-Cell, Diffuse 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Myeloproliferative Disorders 27Lymphoma, Follicular 27Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, Mantle-Cell 24Leukemia, Myeloid, Chronic-Phase 23Leukemia, Eosinophilic, Acute 23Hodgkin Disease 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Basophilic, Acute 22

Interventions

Cyclophosphamide 19fludarabine phosphate 18Whole-Body Irradiation 16Melphalan 15fludarabine 13Tacrolimus 13Busulfan 13Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Antilymphocyte Serum 6Alemtuzumab 6Methotrexate 5Cyclosporine 5Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3Transplantation 2Sirolimus 2Rituximab 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Cord Blood Stem Cell Transplantation 2visilizumab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Cytarabine × Other hematologic neoplasm × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡